Optipharm.CO.LTD (153710) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.016x

Based on the latest financial reports, Optipharm.CO.LTD (153710) has a cash flow conversion efficiency ratio of -0.016x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-408.70 Million ≈ $-276.97K USD) by net assets (₩25.40 Billion ≈ $17.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 153710 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Optipharm.CO.LTD - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Optipharm.CO.LTD's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Optipharm.CO.LTD Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Optipharm.CO.LTD ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lexibook Linguistic Electronic System SA PA:ALLEX	-0.217x
Hong Yi Fiber Industry Co Ltd TW:1452	-0.021x
Rockhaven Resources Ltd V:RK	-0.001x
Kolon Industries Inc KO:120115	0.031x
Silvano Fashion Group AS WAR:SFG	0.016x
Purple Innovation Inc NASDAQ:PRPL	-0.050x
Athanase Innovation AB ST:ATIN	-0.026x
InBioGen Co Ltd KO:101140	-0.010x

Annual Cash Flow Conversion Efficiency for Optipharm.CO.LTD (2015–2025)

The table below shows the annual cash flow conversion efficiency of Optipharm.CO.LTD from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 153710 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩25.40 Billion ≈ $17.21 Million	₩-1.55 Billion ≈ $-1.05 Million	-0.061x	-180.98%
2024-12-31	₩27.34 Billion ≈ $18.52 Million	₩-595.50 Million ≈ $-403.56K	-0.022x	+68.20%
2023-12-31	₩25.14 Billion ≈ $17.04 Million	₩-1.72 Billion ≈ $-1.17 Million	-0.069x	+18.34%
2022-12-31	₩29.01 Billion ≈ $19.66 Million	₩-2.43 Billion ≈ $-1.65 Million	-0.084x	-31.87%
2021-12-31	₩30.96 Billion ≈ $20.98 Million	₩-1.97 Billion ≈ $-1.33 Million	-0.064x	-32.95%
2020-12-31	₩33.78 Billion ≈ $22.89 Million	₩-1.62 Billion ≈ $-1.10 Million	-0.048x	-480.82%
2019-12-31	₩35.61 Billion ≈ $24.13 Million	₩447.47 Million ≈ $303.24K	0.013x	-62.99%
2018-12-31	₩35.44 Billion ≈ $24.02 Million	₩1.20 Billion ≈ $815.47K	0.034x	+66.43%
2017-12-31	₩12.79 Billion ≈ $8.67 Million	₩260.86 Million ≈ $176.78K	0.020x	-68.03%
2016-12-31	₩13.50 Billion ≈ $9.15 Million	₩861.36 Million ≈ $583.73K	0.064x	+136.47%
2015-12-31	₩4.30 Billion ≈ $2.91 Million	₩-751.51 Million ≈ $-509.29K	-0.175x	--

About Optipharm.CO.LTD

KQ:153710 Korea Diagnostics & Research

Market Cap

$46.58 Million

₩68.73 Billion KRW

Market Cap Rank

#22235 Global

#1380 in Korea

Share Price

₩4685.00

Change (1 day)

-2.40%

52-Week Range

₩4400.00 - ₩6200.00

All Time High

₩28900.00